Health Care
Business & Economics
Three Blind Men And The Health Care Industry
Today’s hearing in front of the Senate Finance Committee will, unfortunately, be another wasted opportunity. Surely, Senators will make grandiose speeches and be shocked at the cost of drugs. They will also continue to support the very policies that are causing the problems the hearing is supposed to address. A February 25th editorial ...
Blog
Round 1: Old Left vs. Far Left
They say that age and cunning always beats youth and exuberance. But when it comes to the latest dust-up between the Left’s old guard and the new Far Left, how it all plays out in the end isn’t so clear. The Left’s old guard has reacted with smug disdain to ...
Commentary
Governor’s health care proposal puts politics before patients
In California, politics is taking precedence over patients. That’s the only conclusion to draw from Gov. Gavin Newsom’s recently released health care plan. He’s looking to impose price controls on prescription drugs. He’d like to expand Medicaid to undocumented immigrants up to the age of 26. He’s called for re-imposing ...
Commentary
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Commentary
Democratic 2020 Hopefuls: All Roads Lead To Single-Payer
The Democratic Party’s presidential hopefuls are diverse in all ways but one — their stance on healthcare reform. The front-runners want to eliminate private insurance and put everyone on a government-run plan. But that’s not something they’ve been enthusiastic about revealing to voters. Senator Elizabeth Warren recently refused to say whether she would ...
Commentary
Don’t blame drug companies for high prices
*Featured in Kaiser Health News Morning Briefing* Today, Type 1 diabetes patients pay twice as much for insulin as they did in 2012. This is outrageous — but drug companies aren’t to blame. The problem is a dysfunctional supply chain that benefits everyone except patients. In today’s system, insurers hire third-party firms, ...
Commentary
You should absolutely believe Kamala Harris: ‘Medicare for All’ will kill your health insurance
Sen. Kamala Harris, D-Calif., wants to ban private health insurance. But if she can’t do that outright, she’s happy settling for a reform that will eventually take away private health coverage. Harris, who is pursuing the Democratic nomination for president in 2020, spoke honestly about her proposal for the healthcare ...
Commentary
The GND: Glitter, Nonsense, and Devitalization
By Andrew I. Fillat and Henry I. Miller The latest public policy bandwagon is the “Green New Deal,” or GND, whose acronym could well stand for Glitter, Nonsense, and Devitalization. Some of its proposals are so outlandish that they would be more appropriate coming from enthusiastic (but not very smart) ...
Agriculture
Do organic farms really produce ‘chemical free, healthier food’?
In “The Wealth of Nations,” the 18th century economist and philosopher Adam Smith observed about the chicanery of some businessmen, “People of the same trade seldom meet together, even for merriment and diversion, but the conversation ends in a conspiracy against the public, or in some contrivance to raise prices.” ...
Business & Economics
Fostering Transparency In The Pharmaceutical Market
In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation worse because they fail to ...
Three Blind Men And The Health Care Industry
Today’s hearing in front of the Senate Finance Committee will, unfortunately, be another wasted opportunity. Surely, Senators will make grandiose speeches and be shocked at the cost of drugs. They will also continue to support the very policies that are causing the problems the hearing is supposed to address. A February 25th editorial ...
Round 1: Old Left vs. Far Left
They say that age and cunning always beats youth and exuberance. But when it comes to the latest dust-up between the Left’s old guard and the new Far Left, how it all plays out in the end isn’t so clear. The Left’s old guard has reacted with smug disdain to ...
Governor’s health care proposal puts politics before patients
In California, politics is taking precedence over patients. That’s the only conclusion to draw from Gov. Gavin Newsom’s recently released health care plan. He’s looking to impose price controls on prescription drugs. He’d like to expand Medicaid to undocumented immigrants up to the age of 26. He’s called for re-imposing ...
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Democratic 2020 Hopefuls: All Roads Lead To Single-Payer
The Democratic Party’s presidential hopefuls are diverse in all ways but one — their stance on healthcare reform. The front-runners want to eliminate private insurance and put everyone on a government-run plan. But that’s not something they’ve been enthusiastic about revealing to voters. Senator Elizabeth Warren recently refused to say whether she would ...
Don’t blame drug companies for high prices
*Featured in Kaiser Health News Morning Briefing* Today, Type 1 diabetes patients pay twice as much for insulin as they did in 2012. This is outrageous — but drug companies aren’t to blame. The problem is a dysfunctional supply chain that benefits everyone except patients. In today’s system, insurers hire third-party firms, ...
You should absolutely believe Kamala Harris: ‘Medicare for All’ will kill your health insurance
Sen. Kamala Harris, D-Calif., wants to ban private health insurance. But if she can’t do that outright, she’s happy settling for a reform that will eventually take away private health coverage. Harris, who is pursuing the Democratic nomination for president in 2020, spoke honestly about her proposal for the healthcare ...
The GND: Glitter, Nonsense, and Devitalization
By Andrew I. Fillat and Henry I. Miller The latest public policy bandwagon is the “Green New Deal,” or GND, whose acronym could well stand for Glitter, Nonsense, and Devitalization. Some of its proposals are so outlandish that they would be more appropriate coming from enthusiastic (but not very smart) ...
Do organic farms really produce ‘chemical free, healthier food’?
In “The Wealth of Nations,” the 18th century economist and philosopher Adam Smith observed about the chicanery of some businessmen, “People of the same trade seldom meet together, even for merriment and diversion, but the conversation ends in a conspiracy against the public, or in some contrivance to raise prices.” ...
Fostering Transparency In The Pharmaceutical Market
In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation worse because they fail to ...
